Pharmaceutical

NanoSyrinx secures funds to develop biologic therapeutics

NanoSyrinx has secured £10m ($13m) aimed at advancing its technology for targeted intracellular delivery of biologic therapeutics.

Sep 12, 2024 - 04:00
NanoSyrinx secures funds to develop biologic therapeutics
NanoSyrinx has secured £10m ($13m) aimed at advancing its technology for targeted intracellular delivery of biologic therapeutics.
Read the original article

Tags:

Previous Article

EASD 2024: Novo Nordisk’s Saxenda shows weight loss in children

Next Article

FDA grants breakthrough therapy status to Arrowhead’s plozasiran

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’t hold up to scrutiny

Vivek Ramaswamy wants to ‘gut’ the FDA. His claims don’...

Aug 1, 2023

Inovio’s INO-3107 receives orphan drug status from EC

Inovio’s INO-3107 receives orphan drug status from EC

May 24, 2023

TORL scores $158m in Series B2 to advance ADC cancer therapies

TORL scores $158m in Series B2 to advance ADC cancer th...

Apr 11, 2024